BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Stuart McPherson, Shion Gosrani, Sarah Hogg, Preya Patel, Aaron Wetten, Rachael Welton, Kate Hallsworth, Matthew Campbell. Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis CBMJ Open Gastroenterology 2020; 7(1): e000470 doi: 10.1136/bmjgast-2020-000470
2
Urša Kovač, Cene Skubic, Laura Bohinc, Damjana Rozman, Tadeja Režen. Oxysterols and Gastrointestinal Cancers Around the ClockFrontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00483
3
Christa Buechler, Charalampos Aslanidis. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(5): 158658 doi: 10.1016/j.bbalip.2020.158658
4
Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Tatsuo Kanda. Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis CPLOS ONE 2019; 14(1): e0208858 doi: 10.1371/journal.pone.0208858
5
Tawfik Khoury, Amir Mari, Hana Amara, Mohamed Jabaren, Abdulla Watad, Wiliam Nseir, Wisam Sbeit, Mahmud Mahamid. Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux DiseaseCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/6415757
6
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal HypertensionClinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
7
Niki Katsiki, Vasilios G Athyros. Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatmentCurrent Medical Research and Opinion 2019; 35(7): 1305 doi: 10.1080/03007995.2019.1589152
8
Yue Chang, Qinyu Liu, Zidong Zhou, Yuping Ding, Mei Yang, Wei Xu, Kai Chen, Qing Zhang, Zhenguo Wang, Hai Li. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-AnalysisTechnology in Cancer Research & Treatment 2020; 19: 153303382093488 doi: 10.1177/1533033820934881
9
V. Ye. Molodtsov, O. I. Fediv, G. Ya. Stupnytska. ЕФЕКТИВНІСТЬ ЗАСТОСУВАННЯ АТОРВАСТАТИНУ ПРИ ПОЄДНАННІ АЛКОГОЛЬНОЇ ХВОРОБИ ПЕЧІНКИ ТА АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇЗдобутки клінічної і експериментальної медицини 2020; (2): 126 doi: 10.11603/1811-2471.2020.v.i2.11188
10
Christopher Kasia, Steven J. Scaglione. Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin MedicationsClinical Liver Disease 2019; 13(4): 106 doi: 10.1002/cld.788
11
Abdolkhaleg Deezagi, Naser Safari. Rosuvastatin inhibit spheroid formation and epithelial–mesenchymal transition (EMT) in prostate cancer PC-3 cell lineMolecular Biology Reports 2020;  doi: 10.1007/s11033-020-05918-1
12
Sneha Kothari, Hiteshi Dhami-Shah, Samir R. Shah. Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2019; 9(6): 723 doi: 10.1016/j.jceh.2019.06.003
13
Antonio Magan-Fernandez, Manfredi Rizzo, Giuseppe Montalto, Giulio Marchesini. Statins in liver disease: not only prevention of cardiovascular eventsExpert Review of Gastroenterology & Hepatology 2018; 12(8): 743 doi: 10.1080/17474124.2018.1477588
14
Daniela M. Santos, Lorena Pantano, Gina Pronzati, Paula Grasberger, Clemens K. Probst, Katharine E. Black, Jillian J. Spinney, Lida P. Hariri, Royale Nichols, Yufei Lin, Michael Bieler, Peter Seither, Paul Nicklin, David Wyatt, Andrew M. Tager, Benjamin D. Medoff. Screening for YAP Inhibitors Identifies Statins as Modulators of FibrosisAmerican Journal of Respiratory Cell and Molecular Biology 2020; 62(4): 479 doi: 10.1165/rcmb.2019-0296OC
15
Armita M. Gorabi, Nasim Kiaie, Vanessa Bianconi, Tannaz Jamialahmadi, Khalid Al-Rasadi, Thomas P. Johnston, Matteo Pirro, Amirhossein Sahebkar. Antiviral effects of statinsProgress in Lipid Research 2020; 79: 101054 doi: 10.1016/j.plipres.2020.101054
16
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
17
Peter Jarcuska, Ahmed Abdel-Razik, Robert Flisiak, Ram B. Singh. Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular RiskCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7369314
18
Narendra S. Choudhary, Sanjiv Saigal, Neeraj Saraf, Arvinder S. Soin. Acute Onset Significant Muscle Weakness in a Patient Awaiting Liver Transplantation: Look for StatinsJournal of Clinical and Experimental Hepatology 2017; 7(1): 66 doi: 10.1016/j.jceh.2016.09.007
19
Pamela Tietz-Bogert, Minsuk Kim, Angela Cheung, James Tabibian, Julie Heimbach, Charles Rosen, Madhumitha Nandakumar, Konstantinos Lazaridis, Nicholas LaRusso, Jaeyun Sung, Steven O’Hara. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing CholangitisInternational Journal of Molecular Sciences 2018; 19(10): 3188 doi: 10.3390/ijms19103188
20
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foesAtherosclerosis 2019; 284: 66 doi: 10.1016/j.atherosclerosis.2019.02.028